Angelini Ventures is the corporate venture capital arm of Angelini Industries, based in Rome, Italy. It invests in and partners with companies shaping the future of biotech and digital health, managing €300 million in capital.
36% of their portfolio is in Biotech & Life Sciences. Deal activity increased 67% year-over-year (10 deals in the last 12 months). Their most common stage is series-a (41% of deals). Average disclosed round size is $52.8M (across 21 rounds with reported amounts).
Portfolio
30
Fund Size
—
Top Stage
Series A
Last 12 Mo
10
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
39 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Epicrispr Biotechnologies | Series C | $90M | Aug 2026 |
 Handspring Health Inc. | Series B | $19M | Jul 2026 |
 Handspring | Series B | $19M | Jul 2026 |
| CCour Pharma | Series B | $50M | Jun 2026 |
 NUCLIDIUM AG | Unknown | — | May 2026 |
| CCour Pharma | Series B | $50M | Jan 2026 |
 Laigo Bio | Seed | — | Dec 2025 |
 Comind | Unknown | $102.5M | Oct 2025 |
 Comindtechnologies | Series C | $60M | Oct 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Serenis | Series B | $12M | Oct 2025 |
| NUCLIDIUM AG | Unknown | $79M | Jul 2025 |
 Elkedonia | Seed | — | Jun 2025 |
 Therini Bio | Series A | $39M | May 2025 |
 Vantis Health | Series A | — | Mar 2025 |
 Nobi | Series B | — | Jan 2025 |
| NUCLIDIUM AG | Series B | — | Jan 2025 |
 Nuevocor | Series B | $45M | Jan 2025 |
| Vantis Health | Series A | — | Jan 2025 |
 Freya Biosciences | Series A | — | Nov 2024 |
 Avation Medical | Series C | $22M | Feb 2024 |
| CCour Pharma | Series A | $105M | Jan 2024 |
 Noctrix Health | Series C | $40M | Jan 2024 |
 Noctrix Health | Series C | $40M | Jan 2024 |
 Nouscom | Series C | — | Nov 2023 |
Page 1 of 2
Top Co-Investors
Kurma Partners7 shared
Bayern Kapital6 shared
Roche Venture Fund4 shared
Alpha Wave Global4 shared
Pfizer Ventures4 shared
Vesper Holding4 shared
Sanofi Ventures4 shared
Bpifrance3 shared
Eurazeo3 shared
Asahi Kasei3 shared
firstminute capital3 shared
b2venture3 shared
Wellington Management3 shared
Neva SGR3 shared
Andera Partners2 shared
OrbiMed2 shared
Sectoral Asset Management2 shared
Cancer Research Horizons2 shared
Crane Venture Partners2 shared
Octopus Ventures2 shared
Last updated: 7 October 2026